Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Uterine Cervical Neoplasms 1Prostatic Neoplasms 1Neoplasms 1Fatigue 1Castration-Resistant Prostate Carcinoma 1Castration Resistant Metastatic Prostate Cancer 1Carcinoma, Squamous Cell 1Cachexia 1

Interventions

Modafinil 14Surveys and Questionnaires 6Methylphenidate 6Yoga 4Educational Status 3Ultraviolet Therapy 2Therapeutics 2Sugars 2Palliative Care 2Donepezil 2Dexamethasone 2Calcium Dobesilate 2Asian ginseng 2Acceptance and Commitment Therapy 2testosterone enanthate 1testosterone 17 beta-cypionate 1regorafenib 1ofatumumab 1exemestane 1eicosapentaenoic acid ethyl ester 1eicosapentaenoic acid ethanolamide 1dexamethasone acetate 1dexamethasone 21-phosphate 1coenzyme Q10 1caffeine, sodium benzoate drug combination 1auricularum 1Vitamin E 1Triptorelin Pamoate 1Transcranial Magnetic Stimulation 1Transcranial Direct Current Stimulation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Fatigue × testosterone enanthate × Clear all
NCT00965341 2016-09-13

Testosterone Replacement for Fatigue in Male Hypogonadic Advanced Cancer Patients

M.D. Anderson Cancer Center

Phase 3 Completed
53 enrolled 8 charts

Fatigue, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡